| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |